Drugs / Chondroitin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT00691678 | Oct 2008 → Jul 2012 | arthropathy, breast cancer | Dawn L. Hershman | Completed | Met primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT00955552 | Aug 2010 → Feb 2011 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05321836 | Jul 2021 → Mar 2022 | osteoarthritis, knee | Muhammad salman, PT | Completed | No outcome recorded |
| — | NCT00086229 | Apr 2004 → Jan 2006 | osteoarthritis | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03936192 Comparator | Jan 2019 → Feb 2021 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Withdrawn | No outcome recorded |
| Phase 4 | NCT02178137 Comparator | Jun 2014 → Sep 2017 | osteoarthritis, knee | Indus Hospital and Health Network | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chondroitin | “Glucosamine Chondroitin” NCT05321836 ↗ |
| Route | Oral | “oral capsule of glucosamine hydrochloride 500 mg + chondroitin sulphate 400 mg thrice daily before meals.” NCT00955552 ↗ |